暗記メーカー

暗記メーカー

​
ログイン

NCM 106-R PHARMACOLOGY

NCM 106-R PHARMACOLOGY
12問 • 1年前
  • ユーザ名非公開
    • 通報

    問題一覧

  • 1

    mass or swelling in or on the body

    Tumor

  • 2

    new, altered and abnormal development of cells that may be benign or malignant

    Neoplasia

  • 3

    Infiltrates surrounding tissues

    Malignant

  • 4

    Remains localized

    Benign

  • 5

    Common after sx

    Malignant

  • 6

    Not harmful to host

    Benign

  • 7

    cure & control not possible; but maintain quality of life as high as possible

    Palliative

  • 8

    the aim of this modality is to make sure that the client will be disease-free & live normal expectancy

    Cure

  • 9

    not curing but controlling by therapy over long periods of time

    Control

  • 10

    involves treatment with agents derived from biologic sources or with agents that affect biologic responses like interferons, interleukins, and monoclonal antibodies

    Immunotherapy or biotherapy

  • 11

    this involves administering cytotoxic drug to intervene and interrupt the cell cycle

    Chemotherapy

  • 12

    used for radiosensitive cancers like skin cancer, head and neck tumors, cervical cancer, seminoma and early stage Hodgkin’s; the response of the cancer cells depend on the type and phase of cell cycle

    Radiotherapy

    • NCM 104- RA Community Health Nursing (PRELIM)

    NCM 104- RA Community Health Nursing (PRELIM)

    ユーザ名非公開 · 43問 · 1年前

    NCM 104- RA Community Health Nursing (PRELIM)

    NCM 104- RA Community Health Nursing (PRELIM)

    43問 • 1年前
    ユーザ名非公開

    NCM 104- RC ( Community Health Nursing) (PRELIM)

    NCM 104- RC ( Community Health Nursing) (PRELIM)

    ユーザ名非公開 · 75問 · 1年前

    NCM 104- RC ( Community Health Nursing) (PRELIM)

    NCM 104- RC ( Community Health Nursing) (PRELIM)

    75問 • 1年前
    ユーザ名非公開

    GCAS 19 (NSTP) (PRELIM)

    GCAS 19 (NSTP) (PRELIM)

    ユーザ名非公開 · 56問 · 1年前

    GCAS 19 (NSTP) (PRELIM)

    GCAS 19 (NSTP) (PRELIM)

    56問 • 1年前
    ユーザ名非公開

    NCM 108-R (Bioethics) (PRELIM)

    NCM 108-R (Bioethics) (PRELIM)

    ユーザ名非公開 · 69問 · 1年前

    NCM 108-R (Bioethics) (PRELIM)

    NCM 108-R (Bioethics) (PRELIM)

    69問 • 1年前
    ユーザ名非公開

    NCM 104-RA (Community Health Nursing) MIDTERM

    NCM 104-RA (Community Health Nursing) MIDTERM

    ユーザ名非公開 · 60問 · 1年前

    NCM 104-RA (Community Health Nursing) MIDTERM

    NCM 104-RA (Community Health Nursing) MIDTERM

    60問 • 1年前
    ユーザ名非公開

    NCM 104-RB (10 Herbal Medicine)

    NCM 104-RB (10 Herbal Medicine)

    ユーザ名非公開 · 16問 · 1年前

    NCM 104-RB (10 Herbal Medicine)

    NCM 104-RB (10 Herbal Medicine)

    16問 • 1年前
    ユーザ名非公開

    NCM 104-RB (Community Health Nursing) (MIDTERM)

    NCM 104-RB (Community Health Nursing) (MIDTERM)

    ユーザ名非公開 · 43問 · 1年前

    NCM 104-RB (Community Health Nursing) (MIDTERM)

    NCM 104-RB (Community Health Nursing) (MIDTERM)

    43問 • 1年前
    ユーザ名非公開

    NCM 108-R (Bioethics- Midterm)

    NCM 108-R (Bioethics- Midterm)

    ユーザ名非公開 · 52問 · 1年前

    NCM 108-R (Bioethics- Midterm)

    NCM 108-R (Bioethics- Midterm)

    52問 • 1年前
    ユーザ名非公開

    GCAS- NSTP (Midterm)

    GCAS- NSTP (Midterm)

    ユーザ名非公開 · 38問 · 1年前

    GCAS- NSTP (Midterm)

    GCAS- NSTP (Midterm)

    38問 • 1年前
    ユーザ名非公開

    NCM 104-RA (Child Health Services) SEMI FINAL

    NCM 104-RA (Child Health Services) SEMI FINAL

    ユーザ名非公開 · 38問 · 1年前

    NCM 104-RA (Child Health Services) SEMI FINAL

    NCM 104-RA (Child Health Services) SEMI FINAL

    38問 • 1年前
    ユーザ名非公開

    NCM 104-RA (Prevention and Control of Non Communicable Diseases) SEMI FINAL

    NCM 104-RA (Prevention and Control of Non Communicable Diseases) SEMI FINAL

    ユーザ名非公開 · 51問 · 1年前

    NCM 104-RA (Prevention and Control of Non Communicable Diseases) SEMI FINAL

    NCM 104-RA (Prevention and Control of Non Communicable Diseases) SEMI FINAL

    51問 • 1年前
    ユーザ名非公開

    NCM 108 Bioethics

    NCM 108 Bioethics

    ユーザ名非公開 · 35問 · 1年前

    NCM 108 Bioethics

    NCM 108 Bioethics

    35問 • 1年前
    ユーザ名非公開

    NCM 110- RA TYPE A (Prelim)

    NCM 110- RA TYPE A (Prelim)

    ユーザ名非公開 · 30問 · 1年前

    NCM 110- RA TYPE A (Prelim)

    NCM 110- RA TYPE A (Prelim)

    30問 • 1年前
    ユーザ名非公開

    NCM 110- RA TYPE B (Prelim)

    NCM 110- RA TYPE B (Prelim)

    ユーザ名非公開 · 12問 · 1年前

    NCM 110- RA TYPE B (Prelim)

    NCM 110- RA TYPE B (Prelim)

    12問 • 1年前
    ユーザ名非公開

    THE COMPUTER SYSTEM

    THE COMPUTER SYSTEM

    ユーザ名非公開 · 21問 · 1年前

    THE COMPUTER SYSTEM

    THE COMPUTER SYSTEM

    21問 • 1年前
    ユーザ名非公開

    NCM 110- RA Midterm

    NCM 110- RA Midterm

    ユーザ名非公開 · 16問 · 1年前

    NCM 110- RA Midterm

    NCM 110- RA Midterm

    16問 • 1年前
    ユーザ名非公開

    問題一覧

  • 1

    mass or swelling in or on the body

    Tumor

  • 2

    new, altered and abnormal development of cells that may be benign or malignant

    Neoplasia

  • 3

    Infiltrates surrounding tissues

    Malignant

  • 4

    Remains localized

    Benign

  • 5

    Common after sx

    Malignant

  • 6

    Not harmful to host

    Benign

  • 7

    cure & control not possible; but maintain quality of life as high as possible

    Palliative

  • 8

    the aim of this modality is to make sure that the client will be disease-free & live normal expectancy

    Cure

  • 9

    not curing but controlling by therapy over long periods of time

    Control

  • 10

    involves treatment with agents derived from biologic sources or with agents that affect biologic responses like interferons, interleukins, and monoclonal antibodies

    Immunotherapy or biotherapy

  • 11

    this involves administering cytotoxic drug to intervene and interrupt the cell cycle

    Chemotherapy

  • 12

    used for radiosensitive cancers like skin cancer, head and neck tumors, cervical cancer, seminoma and early stage Hodgkin’s; the response of the cancer cells depend on the type and phase of cell cycle

    Radiotherapy